Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

02 May 2003

Regulation of microglial functions by PARP-1 – a target for therapeutic interventions?

O. Ullrich

Med Sci Monit 2003; 9(1): 73-0 :: ID: 15216

Abstract

During the last decade of neurobiological research, it has become evident that inflammatory pathways in the CNS, involving a network of non-neuronal and neuronal cells, are important contributors to the onset and progress of several major neurodegenerative diseases [1]. One major component of inflammatory neuronal damage is the transformation of microglia cells into activated immunoeffector cells and their migration towards the sites of injury, where they produce large amounts of toxic cytokines and oxygen radicals [2]. During this transformation, PARP-1 is highly activated and enables microglia cells to cope with oxidative challenges, in particular by upregulating the proteasomal degradation of damaged nuclear proteins [3]. Besides the initiation of intracellular defense pathways, PARP-1-dependent signalling is also involved in regulating specific functions of activated microglia: It regulates the expression of the integrin CD11a through interaction with the translocated NF-kB and therefore strongly controls migration into the regions of neuronal injury [4]. Furthermore, it enhances the production of the proinflammatory cytokine TNF-alpha and of the antiinflammatory endocannabinoid 2-AG, which in turn downregulates the release of nitric oxide. We are therefore considering PARP-1 to be a multiple player in the concert of neuroinflammation, in which therapeutic interventions directed against PARP-1 would affect both neuronal and non-neuronal components. Downregulation of PARP-1 specifically in microglia almost completely abrogates microglial migration and prevents neurons from secondary damage. This renders PARP-1 a target for therapeutic strategies in neurodegenerative diseases, in which pathological microglia activation and migration play a major role. References: 1.Floyd RA et al: Free Radic Biol Med, 1999; 26: 1346-1355 2.Mabuchi T et al: Stroke, 2000; 31(7): 1735-1743 3.McGeer PL et al: Brain Res Rev, 1995; 21: 195-218 4.Ullrich O et al: FASEB J, 2001; 15: 1460-1462 5.Ullrich O et al: Nature Cell Biol, 2001; 3: 1035-1042

Keywords: neuroinflammation, Microglia, Cytokines, Integrins

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

18 Mar 2024 : Clinical Research  

Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative Study

Med Sci Monit In Press; DOI: 10.12659/MSM.944136  

0:00

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

Most Viewed Current Articles

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750